Resultados da busca - J. Elizabeth Pease
- Mostrando 1 - 3 resultados de 3
-
1
Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patients with advanced solid tumours por Melissa L. Johnson, Judy S. Wang, Gerald S. Falchook, Carol Greenlees, Suzanne F. Jones, Donald K. Strickland, Giulia Fabbri, Caroline Kennedy, J. Elizabeth Pease, Liz Sainsbury, Alexander MacDonald, Stein Schalkwijk, Philip G. Szekeres, Jan Cosaert, Howard A. Burris
Publicado em 2023Artigo -
2
Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers por Jorge E. Cortés, Kenji Tamura, Daniel J. DeAngelo, Johann S. de Bono, David Lorente, Mark D. Minden, Geoffrey L. Uy, Hagop M. Kantarjian, Lisa S. Chen, Varsha Gandhi, Robert Godin, Karen Keating, Kristen McEachern, Karthick Vishwanathan, J. Elizabeth Pease, Emma Dean
Publicado em 2018Artigo -
3
AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in <i>KRAS</i>-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib por Vikki Flemington, Emma Jane Davies, David M. Robinson, Linda C. Sandin, Oona Delpuech, Pei Zhang, Lyndsey Hanson, Paul Farrington, Sigourney Bell, Katarzyna Falenta, Francis D. Gibbons, Nicola Lindsay, Aaron Smith, Joanne Wilson, Karen Roberts, Michael Tonge, Philip Hopcroft, Sophie E. Willis, Martine P. Roudier, Claire Rooney, Elizabeth A. Coker, Patricia Jaaks, Mathew J. Garnett, Stephen E. Fawell, Clifford D. Jones, Richard A. Ward, Iain Simpson, Sabina Cosulich, J. Elizabeth Pease, Paul D. Smith
Publicado em 2020Artigo
Ferramentas de busca:
Assuntos relacionados
Pharmacology
Adverse effect
Internal medicine
Medicine
Pharmacodynamics
Pharmacokinetics
Tolerability
Absolute neutrophil count
Biochemistry
Biology
Cancer
Cancer research
Carcinogenesis
Cell biology
Chemistry
Chemotherapy
Colorectal cancer
Dosing
Febrile neutropenia
Gastroenterology
Gene
Genetics
Granulocyte colony-stimulating factor
KRAS
Kinase
MAPK/ERK pathway
MEK inhibitor
Melanoma
Mutant
Neutropenia